Health Catalyst Inc Forecast, price target & analysts
Health Catalyst Inc Target price 2025 - Analyst rating & recommendation
Health Catalyst Inc Classifications & Recommendation:
Health Catalyst Inc Price Target
| Target Price | $8.96 |
| Price | $4.39 |
| Potential |
104.06%
register free of charge
|
| Number of Estimates | 12 |
|
12 Analysts have issued a price target Health Catalyst Inc 2026 .
The average Health Catalyst Inc target price is $8.96.
This is
104.06%
register free of charge
$16.00
264.46%
register free of charge
$5.00
13.90%
register free of charge
|
|
| A rating was issued by 13 analysts: 10 Analysts recommend Health Catalyst Inc to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Health Catalyst Inc stock has an average upside potential 2026 of
104.06%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 306.58 | 334.58 |
| 3.60% | 9.13% | |
| EBITDA Margin | -4.57% | 11.92% |
| 66.63% | 360.66% | |
| Net Margin | -24.02% | -15.75% |
| 46.89% | 34.43% |
13 Analysts have issued a sales forecast Health Catalyst Inc 2025 . The average Health Catalyst Inc sales estimate is
This results in the following potential growth metrics:
13 Analysts have issued an Health Catalyst Inc EBITDA forecast 2025. The average Health Catalyst Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 Health Catalyst Inc Analysts have issued a net profit forecast 2025. The average Health Catalyst Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.15 | -0.82 |
| 44.98% | 28.70% | |
| P/E | negative | |
| EV/Sales | 0.83 |
9 Analysts have issued a Health Catalyst Inc forecast for earnings per share. The average Health Catalyst Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Health Catalyst Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Health Catalyst Inc...
Current Health Catalyst Inc Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RBC Capital | Locked ➜ Locked | Locked | Feb 27 2025 |
| Stephens & Co. | Locked ➜ Locked | Locked | Feb 27 2025 |
| Stifel | Locked ➜ Locked | Locked | Feb 27 2025 |
| Piper Sandler | Locked ➜ Locked | Locked | Feb 11 2025 |
| Canaccord Genuity | Locked ➜ Locked | Locked | Jan 21 2025 |
| Wells Fargo | Locked ➜ Locked | Locked | Jan 21 2025 |
| RBC Capital | Locked ➜ Locked | Locked | Jan 15 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
RBC Capital: Locked ➜ Locked
|
Feb 27 2025 |
|
Locked
Stephens & Co.: Locked ➜ Locked
|
Feb 27 2025 |
|
Locked
Stifel: Locked ➜ Locked
|
Feb 27 2025 |
|
Locked
Piper Sandler: Locked ➜ Locked
|
Feb 11 2025 |
|
Locked
Canaccord Genuity: Locked ➜ Locked
|
Jan 21 2025 |
|
Locked
Wells Fargo: Locked ➜ Locked
|
Jan 21 2025 |
|
Locked
RBC Capital: Locked ➜ Locked
|
Jan 15 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
